/

CPH.TO

CIPHER PHARMACEUTICALS INCClosed

13.35−0.15 −1.11%CAD

Toronto · as of Oct 14, 16:00 ET · 15m delay

Open

13.50

Prev close

13.50

Day range

13.3513.59

52-week range

12.4820.56

Volume

11.49K0.31×

Mkt cap

339.29M

P/E ttm

8.73

Fwd P/E

—

EPS ttm

1.53

Div yield

0.00%

Earnings

Aug 11, 2026

From 52w high

−35.07%

Price Chart

Yahoo Finance · delayed

CPH.TOOct 14, 2026O 13.50H 13.59L 13.35C 13.35−0.15 (−1.11%)Vol 11.49K

SMA 5014.50
SMA 20015.94

1Y change −6.32% since Oct 10, 2025 close540 bars loadedTimes in America/TorontoDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

CPH.TO CIPHER PHARMACEUTICALS INC · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −2.27%
1 month: −9.61%
3 months: −19.77%
6 months: −30.65%
Year to date: −11.35%
1 year: −11.88%

Valuation & ownership

Market cap: 339.29M
Enterprise value: 334.36M
P/E (ttm): 8.73
Forward P/E: —
PEG ratio: —
Price / book: 1.74
Price / sales (ttm): 6.84
EV / EBITDA: 12.63
EPS (ttm): 1.53
EPS (forward): —
Beta (5y monthly): 0.41
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 25.42M
Float: 14.82M
Short % of float: —
Short ratio (days): 1.24
Held by insiders: 42.54%
Held by institutions: 1.28%
Avg volume (3m): 36.85K
50-day average: 14.57
200-day average: 15.95
52-week change: −11.88%
S&P 500 52-week: +17.00%

Technicals (daily)

RSI (14): 32.1
vs 50-day SMA: −7.95%
vs 200-day SMA: −16.23%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▼ below
ATR (14) % of price: 2.20%
Realised vol (20d, ann.): 17.6%
From 52-week high: −35.07%
From 52-week low: +6.97%

ANR

Analyst Consensus

4 analysts

Consensus

—

Mean target

19.45

+45.69% implied

Low 17.00Median 19.75High 21.30

Recommendation trend

Now3 / 1 / 0
1m ago3 / 1 / 0

DES

About CIPHER PHARMACEUTICALS INC

Yahoo Finance profile

Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibrillation to sinus rhythm in adults; Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with acute coronary syndrome; and Natroba for the topical treatment of head lice and scabies infestations in adult and pediatric patients. The company's licensed products comprise Absorica, an oral retinoid for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Conzip, an opioid agonist for the management of moderate to moderately severe chronic pain in adults; and Lipofen, an adjunctive therapy to diet to reduce elevated LDL-C, total-C, triglycerides, and Apo B, as well as to increase HDL-C. Its pipeline products include piclidenoson CF-101, a novel chemical entity for moderate to severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical formulation of terbinafine, which is in phase 3 clinical trial for treatment of onychomycosis; and DTR-001, a tattoo removal cream. The company was founded in 2000 and is headquartered in Mississauga, Canada.

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Headquarters: Mississauga, ON, Canada
Website: cipherpharma.com
Officers

SEAS

Seasonality · CPH.TO

2007–2026 · monthly returns

Strongest month May +12.72%Weakest month Sep −8.33%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-2.9	2.6	21.6	-3.0	-5.8	-0.1	1.0	-18.7	-0.2	-2.2			−11.4%
2025	-5.1	-10.8	5.2	6.0	-7.5	0.3	-3.9	32.2	-2.9	-4.3	2.9	-1.1	+5.2%
2024	6.7	18.6	27.0	-3.5	2.0	-6.4	55.1	49.3	-19.7	-1.3	2.1	-6.7	+158.5%
2023	-10.7	10.8	-13.2	3.0	13.8	-7.8	4.2	6.5	7.3	2.6	44.7	-12.2	+44.3%
2022	-0.6	13.1	14.1	-1.3	6.3	-7.6	-0.5	19.6	23.7	-2.2	10.4	9.7	+116.9%
2021	-3.2	2.2	40.2	0.8	3.1	11.9	2.0	39.2	3.8	14.5	-29.2	-1.1	+90.3%
2020	-30.7	-11.5	-23.9	35.7	29.5	-2.4	15.8	-17.3	-7.0	-7.5	-16.2	12.0	−38.0%
2019	11.7	1.6	-27.8	0.0	-3.6	-3.0	-11.5	11.2	8.5	-15.0	1.7	24.0	−12.3%
2018	-19.2	7.1	-0.9	-13.8	-5.5	-14.6	-1.0	18.7	-5.0	-13.5	-24.5	-19.7	−65.1%
2017	-3.1	-3.2	0.0	-3.3	26.1	1.6	-5.1	-3.9	-8.7	-8.8	15.5	-2.0	+0.0%
2016	-10.8	11.4	-3.3	18.9	2.6	-11.3	-2.5	-15.2	-10.0	-3.4	-19.6	25.6	−24.5%
2015	4.2	-18.2	-19.7	9.2	-1.9	-13.2	-0.4	-33.8	-29.7	9.1	13.3	6.0	−61.3%
2014	0.6	4.0	-6.0	10.9	-6.4	11.5	2.7	19.0	8.6	20.9	8.6	9.1	+116.4%
2013	8.0	-9.3	43.7	3.7	15.1	13.1	48.2	32.1	-32.4	25.6	10.0	-10.9	+209.6%
2012	54.7	31.3	1.5	-22.0	91.3	-21.3	0.0	3.2	0.0	18.7	15.8	13.6	+290.6%
2011	-6.7	-8.9	1.0	-4.9	27.6	-16.0	-11.4	-14.0	-5.0	7.9	3.7	-24.7	−46.7%
2010	150.0	-14.8	2.6	-14.4	8.9	27.3	-16.4	6.8	0.0	11.2	-17.3	4.3	+122.2%
2009	80.0	-13.9	-3.2	-16.7	40.0	-18.6	31.6	0.0	-20.0	-3.3	-5.2	-1.8	+35.0%
2008	8.9	4.1	-36.3	84.6	37.5	-9.7	-26.2	4.5	-39.1	-57.1	50.0	-11.1	−55.6%
2007	-1.5	21.5	3.5	-8.4	-36.8	3.3	-18.1	-3.9	-30.8	-14.8	-14.8	-8.2	−73.1%

INSD

Insider Activity · CPH.TO

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

0 shares

Sells, 6 months

— shares

Net shares

Net change in insider shares

—

Date	Insider	Transaction	Shares	Value
Sep 29, 2026	Cipher Pharmaceuticals, Inc.Issuer	Redemption, retraction, cancelation, repurchase at price 10.18 per share.	133.2K	$1.36M
Sep 29, 2026	Cipher Pharmaceuticals, Inc.Issuer	Redemption, retraction, cancelation, repurchase at price 10.18 per share.	133.2K	$1.36M
Sep 17, 2026	Mull (Craig James)10% Security Holder of Issuer	Disposition in the public market at price 10.12 per share.	20K	$202.48K
Sep 17, 2026	Mull (Craig James)10% Security Holder of Issuer	Exercise of options at price 0.84 per share.	20K	$16.88K
Sep 17, 2026	Mull (Craig James)10% Security Holder of Issuer	Acquisition in the public market at price 10.12 per share.	20K	$202.48K
Sep 1, 2026	Cipher Pharmaceuticals, Inc.Issuer	Redemption, retraction, cancelation, repurchase at price 10.27 per share.	4K	$41.09K
Aug 30, 2026	Cipher Pharmaceuticals, Inc.Issuer	Redemption, retraction, cancelation, repurchase at price 10.26 per share.	70.8K	$726.85K
Aug 30, 2026	Cipher Pharmaceuticals, Inc.Issuer	Redemption, retraction, cancelation, repurchase at price 10.26 per share.	66.8K	$685.79K
Jun 23, 2026	Deeth, Douglas NormanDirector of Issuer	Exercise of rights at price 11.38 per share.	2.5K	$28.44K
Jun 23, 2026	Deeth, Douglas NormanDirector of Issuer	Exercise of rights at price 11.46 per share.	1.1K	$13.17K
Jun 23, 2026	Mull (Craig James)10% Security Holder of Issuer	Exercise of rights at price 11.38 per share.	2.5K	$28.44K
Jun 23, 2026	Walinski (Hubert)Director of Issuer	Exercise of rights at price 11.38 per share.	2.5K	$28.44K
Jun 23, 2026	Walinski (Hubert)Director of Issuer	Exercise of rights at price 11.46 per share.	1.1K	$13.17K
Mar 23, 2026	Mull (Craig James)10% Security Holder of Issuer	Exercise of rights at price 12.22 per share.	83.9K	$1.03M
Mar 19, 2026	Jacobs (Bryan)Senior Officer of Issuer	Exercise of options at price 1.68 per share.	7.5K	$12.62K
Mar 19, 2026	Jacobs (Bryan)Senior Officer of Issuer	Disposition in the public market at price 12.17 per share.	7.5K	$91.27K
Mar 17, 2026	Jacobs (Bryan)Senior Officer of Issuer	Exercise of rights at price 11.80 per share.	4.2K	$49.31K
Mar 17, 2026	Jacobs (Bryan)Senior Officer of Issuer	Exercise of rights at price 12.48 per share.	1.8K	$22.83K
Mar 17, 2026	Jacobs (Bryan)Senior Officer of Issuer	Exercise of options at price 1.68 per share.	7.5K	$12.62K
Mar 17, 2026	Jacobs (Bryan)Senior Officer of Issuer	Disposition in the public market at price 12.58 per share.	7.5K	$94.38K

CPH.TO

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

CPH.TO

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About CIPHER PHARMACEUTICALS INC

Seasonality · CPH.TO

Insider Activity · CPH.TO

Congress Trades · CPH.TO

Investors Holding CPH.TO

Investors Holding CPH.TO

Insider Activity · CPH.TO

Seasonality · CPH.TO

Congress Trades · CPH.TO

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About CIPHER PHARMACEUTICALS INC

Financial Snapshot

Earnings & Dividends

News